Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 06-2011 | 12-2010 | 06-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 875 | 1,492 | 1,178 | 1,334 | 704 |
| Marketable Securities | 1,377 | 3,401 | 2,701 | 3,680 | 6,141 |
| Inventories | 79 | 216 | 267 | 293 | 134 |
| Other current assets | 166 | 455 | 379 | 395 | 296 |
| TOTAL | $2,497 | $5,616 | $4,525 | $5,758 | $7,275 |
| Non-Current Assets | |||||
| PPE Net | 36 | 60 | 74 | 81 | 89 |
| Intangibles | 231 | 240 | 241 | 252 | 205 |
| TOTAL | $267 | $300 | $315 | $333 | $294 |
| Total Assets | $2,764 | $5,916 | $4,840 | $6,091 | $7,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2 | N/A |
| Accounts payable and accrued liabilities | 692 | 137 | 607 | 187 | 716 |
| TOTAL | $692 | $922 | $608 | $527 | $719 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $1 |
| Total Liabilities | $692 | $922 | $608 | $527 | $720 |
| Shareholders' Equity | |||||
| Common Shares | 696 | 696 | 597 | 597 | 597 |
| Retained earnings | -16,235 | -13,313 | -11,573 | -10,241 | -8,956 |
| Other shareholders' equity | 483 | 483 | 483 | 483 | 483 |
| TOTAL | $2,072 | $4,994 | $4,232 | $5,564 | $6,849 |
| Total Liabilities And Equity | $2,764 | $5,916 | $4,840 | $6,091 | $7,569 |